CMS proposes broadening criteria for price control, while CBO warns that such controls could discourage investment in the sector.

The entities involved

• FDA →
  • The illegal U.S. vape market is estimated to be worth $9 billion, fueled by unauthorized imports from China, while products must meet FDA authorization standards.Sun 20:36
  • VDPHL01 and Veradermics, Incorporated are seeking FDA approval for their lead therapies targeting hair loss.Sun 20:31
• Medicare →

  US federal health insurance

  • Medicare reduces Social Security benefit amounts, and the Administration released new estimates for average retired worker benefits.Sun 17:41
  • Medicare Advantage plans operate within defined service areas in Arizona.Sun 16:36
• Congressional Budget Office →

  government agency

  • The Roosevelt administration, timber industry pressures, and CBO projections on Medicaid spending are discussed in relation to Shasta County.Sun 13:49
  • CBO projects that deficits will worsen due to policies enacted by Donald Trump.Sat 14:09

Related events

• CMS introduced the Medicare drug price negotiation program, and companies are facing challenges regarding pricing and market access.Aug 19
• FDA policy proposal affects the operations of AI, Inc.Oct 16
• Congress introduced AI legislation, CMS expanded value-based models, FDA built AI infrastructure, and FTC rescinded a health data breach policy.Oct 15